Vera Therapeutics appointed Amgen and Seagen alum Matt Skelton as EVP of commercial. Frank Lane was appointed SVP and head of ...

The company said it is investing $5 million into an 11,000-square-foot manufacturing facility that it is leasing which is ...

NVAX reports encouraging third-quarter results. However, the stock falls due to management lowering its sales guidance, ...

Sanofi, Johnson and Johnson, Elli Lilly, Bayer AG, GSK plc, Biocare Medical LLC, Teva Pharmaceuticals Industries, Mitsubishi chemical group corporation, Bristol-Myers Squibb Company in the Anxiety ...

While manufacturers know that AI presents a significant opportunity for driving automation and efficiency, many are still in ...

We are also actively exploring the sale of our Czech Republic manufacturing facility ... As we enter 2025, the future cash ...

“The development of Muse, a result of our ongoing collaboration with OpenAI and Formation Bio, represents another proof point ...

Novavax Inc (NVAX) reports increased product sales and a strong cash position, while revising revenue guidance and navigating ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

The company now expects $650 million to $700 million in revenue for the year, down from previous guidance of $700 million to ...